SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
About this item
Full title
Author / Creator
van Kempen, Zoé L E , Stalman, Eileen W , Steenhuis, Maurice , Kummer, Laura Y L , van Dam, Koos P J , Wilbrink, Maarten F , ten Brinke, Anja , van Ham, S Marieke , Kuijpers, Taco , Rispens, Theo , Eftimov, Filip , Wieske, Luuk , Killestein, Joep , vd Kooi, AJ , Raaphorst, J , Koos Zwinderman, AH , Löwenberg, M , Volkers, AG , D'Haens, G.R.A.M , Takkenberg, RB , Tas, SW , Spuls, PI , Bekkenk, MW , Musters, AH , Post, NF , Bosma, AL , Hilhorst, ML , Vegting, Y , Bemelman, FJ , Verstegen, N.J.M. , Fernandez, L , Keijzer, S , Keijser, J.B.D. , Cristianawati, O , Voskuyl, AE , Broens, B , Sanchez, AP , Nejentsev, S , Mirfazeli, ES , Wolbink, GJ , Boekel, L , Rutgers, BA , de Leeuw, K , Horváth, B , Verschuuren, J.J.G.M. , Ruiter, A.M , van Ouwerkerk, L , van der Woude, D , Allaart, RCF , Teng, YKO , Busch, MH , Brusse, E. , van Doorn, PA , Baars, MAE , Hijnen, DJ , Schreurs, CRG , van der Pol, WL , Goedee, HS , van Els, C.A.C.M , de Wit, J and T2B! immunity against SARS-CoV-2 study group
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundIt is unclear which patients with multiple sclerosis (MS) are most susceptible for omicron breakthrough infections.MethodsWe assessed omicron breakthrough infections in vaccinated patients with MS with and without disease-modifying therapies enrolled in an ongoing large prospective study. We longitudinally studied humoral responses after...
Alternative Titles
Full title
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis
Authors, Artists and Contributors
Author / Creator
Stalman, Eileen W
Steenhuis, Maurice
Kummer, Laura Y L
van Dam, Koos P J
Wilbrink, Maarten F
ten Brinke, Anja
van Ham, S Marieke
Kuijpers, Taco
Rispens, Theo
Eftimov, Filip
Wieske, Luuk
Killestein, Joep
vd Kooi, AJ
Raaphorst, J
Koos Zwinderman, AH
Löwenberg, M
Volkers, AG
D'Haens, G.R.A.M
Takkenberg, RB
Tas, SW
Spuls, PI
Bekkenk, MW
Musters, AH
Post, NF
Bosma, AL
Hilhorst, ML
Vegting, Y
Bemelman, FJ
Verstegen, N.J.M.
Fernandez, L
Keijzer, S
Keijser, J.B.D.
Cristianawati, O
Voskuyl, AE
Broens, B
Sanchez, AP
Nejentsev, S
Mirfazeli, ES
Wolbink, GJ
Boekel, L
Rutgers, BA
de Leeuw, K
Horváth, B
Verschuuren, J.J.G.M.
Ruiter, A.M
van Ouwerkerk, L
van der Woude, D
Allaart, RCF
Teng, YKO
Busch, MH
Brusse, E.
van Doorn, PA
Baars, MAE
Hijnen, DJ
Schreurs, CRG
van der Pol, WL
Goedee, HS
van Els, C.A.C.M
de Wit, J
T2B! immunity against SARS-CoV-2 study group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2758116583
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2758116583
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2022-330100
